RetinaVue

RetinaVue is a comprehensive tele-retinal imaging and diagnostic platform designed to facilitate diabetic retinopathy screening within primary care settings. The system integrates handheld, non-mydriatic retinal cameras, such as the RetinaVue 700 Imager, with secure cloud-based software and a network of board-certified ophthalmologists for remote image interpretation. By enabling eye exams during routine primary care visits, RetinaVue significantly increases patient compliance with annual screening requirements and aids in the early detection of vision-threatening conditions. The platform is a key component of Baxter's diagnostic cardiology and vision portfolio, following its acquisition of Hillrom and Welch Allyn. It is widely utilized by healthcare providers and payers to improve HEDIS and Star ratings while lowering the overall cost of care for diabetic populations. RetinaVue, P.C. provides the professional medical services associated with the platform and is the first tele-ophthalmology provider to receive accreditation from The Joint Commission.